Skip to main content

Advertisement

SpringerLink
Log in

Taming expectations of metformin as a treatment to extend healthspan

  • Review
  • Published:
GeroScience Aims and scope Submit manuscript

Abstract

The anti-hyperglycemic medication metformin has potential to be the first drug tested to slow aging in humans. While the Targeting Aging with Metformin (TAME) proposal and other small-scale clinical trials have the potential to support aging as a treatment indication, we propose that the goals of the TAME trial might not be entirely consistent with the Geroscience goal of extending healthspan. There is expanding epidemiological support for the health benefits of metformin in individuals already diagnosed with overt chronic disease. However, it remains to be understood if these protective effects extend to those free of chronic disease. Within this editorial, we seek to highlight critical gaps in knowledge that should be considered when testing metformin as a treatment to target aging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • ADVANCE Collaborative Group, Patel A, Macmahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560–2572

    Article  Google Scholar 

  • Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, Tyndyk ML, Yurova MV, Kovalenko IG, Poroshina TE, Semenchenko AV (2008) Metformin slows down aging and extends life span of female SHR mice. Cell Cycle Georget Tex 7:2769–2773

    Article  CAS  Google Scholar 

  • Anisimov VN, Berstein LM, Popovich IG, Zabezhinski MA, Egormin PA, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Kovalenko IG, Poroshina TE (2011) If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging 3:148–157

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, Mukherjee J, Currie CJ (2014) Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab 16:1165–1173

    Article  CAS  PubMed  Google Scholar 

  • Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA (2016) Metformin as a tool to target aging. Cell Metab 23:1060–1065

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Barzilay JI, Blaum C, Moore T, Xue QL, Hirsch CH, Walston JD, Fried LP (2007) Insulin resistance and inflammation as precursors of frailty: the cardiovascular health study. Arch Intern Med 167:635–641

    Article  PubMed  Google Scholar 

  • Blair SN, Kohl HW, Paffenbarger RS, Clark DG, Cooper KH, Gibbons LW (1989) Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262:2395–2401

    Article  CAS  PubMed  Google Scholar 

  • Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M (2002) HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 25:1135–1141

    Article  PubMed  Google Scholar 

  • Braun B, Eze P, Stephens BR, Hagobian TA, Sharoff CG, Chipkin SR, Goldstein B (2008) Impact of metformin on peak aerobic capacity. Appl Physiol Nutr Metab 33:61–67

    Article  CAS  PubMed  Google Scholar 

  • Bridges HR, Jones AJY, Pollak MN, Hirst J (2014) Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem J 462:475–487

    Article  CAS  PubMed  Google Scholar 

  • Brunmair B, Staniek K, Gras F, Scharf N, Althaym A, Clara R, Roden M, Gnaiger E, Nohl H, Waldhäusl W, Fürnsinn C (2004) Thiazolidinediones, like metformin, inhibit respiratory complex I a common mechanism contributing to their antidiabetic actions? Diabetes 53:1052–1059

    Article  CAS  PubMed  Google Scholar 

  • Buse JB, DeFronzo RA, Rosenstock J, Kim T, Burns C, Skare S, Baron A, Fineman M (2016) The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care 39:198–205

    Article  CAS  PubMed  Google Scholar 

  • Cabreiro F, Au C, Leung K-Y, Vergara-Irigaray N, Cochemé HM, Noori T, Weinkove D, Schuster E, Greene NDE, Gems D (2013) Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 153:228–239

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Campbell JM, Bellman SM, Stephenson MD, Lisy K (2017) Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis. Ageing Res Rev 40:31–44

    Article  CAS  PubMed  Google Scholar 

  • Cartee GD, Hepple RT, Bamman MM, Zierath JR (2016) Exercise promotes healthy aging of skeletal muscle. Cell Metab 23:1034–1047

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheng C, Lin C-H, Tsai Y-W, Tsai C-J, Chou P-H, Lan T-H (2014) Type 2 diabetes and antidiabetic medications in relation to dementia diagnosis. J Gerontol A Biol Sci Med Sci 69:1299–1305

    Article  CAS  PubMed  Google Scholar 

  • Crandall J, Barzilai N (2003) Treatment of diabetes mellitus in older people: oral therapy options. J Am Geriatr Soc 51:272–274

    Article  PubMed  Google Scholar 

  • De Haes W, Frooninckx L, Van Assche R, Smolders A, Depuydt G, Billen J, Braeckman BP, Schoofs L, Temmerman L (2014) Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proc Natl Acad Sci U S A 111:E2501–E2509

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dhahbi JM, Mote PL, Fahy GM, Spindler SR (2005) Identification of potential caloric restriction mimetics by microarray profiling. Physiol Genomics 23:343–350

    Article  CAS  PubMed  Google Scholar 

  • Diabetes Prevention Program Research Group, Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, Dagogo-Jack S, Andres R (2006) The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 61:1075–1081

    Article  Google Scholar 

  • Facchini FS, Hua N, Abbasi F, Reaven GM (2001) Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 86:3574–3578

    Article  CAS  PubMed  Google Scholar 

  • Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, DeCensi A, Szabo E (2014) Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res Phila 7:867–885

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Goodpaster BH, Carlson CL, Visser M, Kelley DE, Scherzinger A, Harris TB, Stamm E, Newman AB (2001) Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol 90:2157–2165

    Article  CAS  PubMed  Google Scholar 

  • Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61:1059–1064

    Article  PubMed  Google Scholar 

  • Gormsen LC, Sundelin EI, Jensen JB, Vendelbo MH, Jakobsen S, Munk OL, Christensen MMH, Brøsen K, Frøkiær J, Jessen N (2016) In vivo imaging of human 11C-metformin in peripheral organs: dosimetry, biodistribution, and kinetic analyses. J Nucl Med 57:1920–1926

    Article  CAS  PubMed  Google Scholar 

  • Hartman MHT, Prins JKB, Schurer RAJ, Lipsic E, Lexis CPH, van der Horst-Schrivers ANA, van Veldhuisen DJ, van der Horst ICC, van der Harst P (2017) Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT. Clin Res Cardiol 106:939–946

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Iannello S, Camuto M, Cavaleri A, Milazzo P, Pisano MG, Bellomia D, Belfiore F (2004) Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids. Diabetes Obes Metab 6:8–15

    Article  CAS  PubMed  Google Scholar 

  • Imboden MT, Harber MP, Whaley MH, Finch WH, Bishop DL, Kaminsky LA (2018) Cardiorespiratory fitness and mortality in healthy men and women. J Am Coll Cardiol 72:2283–2292

    Article  PubMed  Google Scholar 

  • Justice JN, Ferrucci L, Newman AB, Aroda VR, Bahnson JL, Divers J, Espeland MA, Marcovina S, Pollak MN, Kritchevsky SB, Barzilai N, Kuchel GA (2018) A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup. GeroScience 40:419–436

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kaeberlein M (2018) How healthy is the healthspan concept? GeroScience 40:361–364

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kane DA, Anderson EJ, Price JW, Woodlief TL, Lin C-T, Bikman BT, Cortright RN, Neufer PD (2010) Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats. Free Radic Biol Med 49:1082–1087

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403

    Article  CAS  PubMed  Google Scholar 

  • Konopka AR, Esponda RR, Robinson MM, Johnson ML, Carter RE, Schiavon M, Cobelli C, Wondisford FE, Lanza IR, Nair KS (2016) Hyperglucagonemia mitigates the effect of metformin on glucose production in prediabetes. Cell Rep 15:1394–1400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Konopka AR, Laurin JL, Schoenberg HM, Reid JJ, Castor WM, Wolff CA, Musci RV, Safairad OD, Linden MA, Biela LM, Bailey SM, Hamilton KL, Miller BF (2018) Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell e12880

  • Kristensen JM, Larsen S, Helge JW, Dela F, Wojtaszewski JFP (2013) Two weeks of metformin treatment enhances mitochondrial respiration in skeletal muscle of AMPK kinase dead but not wild type mice. PLoS One 8:e53533

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kulkarni AS, Brutsaert EF, Anghel V, Zhang K, Bloomgarden N, Pollak M, Mar JC, Hawkins M, Crandall JP & Barzilai N (2018) Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults. Aging Cell 17

  • Larsen S, Rabøl R, Hansen CN, Madsbad S, Helge JW, Dela F (2011) Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration. Diabetologia 55:443–449

    Article  CAS  PubMed  Google Scholar 

  • Lee H, Ko G (2014) Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol 80:5935–5943

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lexis CPH, van der Horst ICC, Lipsic E, Wieringa WG, de Boer RA, van den Heuvel AFM, van der Werf HW, Schurer RAJ, Pundziute G, Tan ES, Nieuwland W, Willemsen HM, Dorhout B, Molmans BHW, van der Horst-Schrivers ANA, Wolffenbuttel BHR, ter Horst GJ, van Rossum AC, Tijssen JGP, Hillege HL, de Smet BJGL, van der Harst P, van Veldhuisen DJ, Investigators GIPS-III (2014) Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. JAMA 311:1526–1535

    Article  CAS  PubMed  Google Scholar 

  • Linden MA, Lopez KT, Fletcher JA, Morris EM, Meers GM, Siddique S, Laughlin MH, Sowers JR, Thyfault JP, Ibdah JA, Rector RS (2015) Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats. Appl Physiol Nutr Metab Physiol Appl Nutr Metab 40:1038–1047

    Article  CAS  Google Scholar 

  • Long DE, Peck BD, Martz JL, Tuggle SC, Bush HM, McGwin G, Kern PA, Bamman MM & Peterson CA (2017) Metformin to Augment Strength Training Effective Response in Seniors (MASTERS): study protocol for a randomized controlled trial. Trials 18. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405504/ [Accessed January 25, 2019]

  • Madiraju AK, Erion DM, Rahimi Y, Zhang X-M, Braddock DT, Albright RA, Prigaro BJ, Wood JL, Bhanot S, MacDonald MJ, Jurczak MJ, Camporez J-P, Lee H-Y, Cline GW, Samuel VT, Kibbey RG, Shulman GI (2014) Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510:542–546

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Madiraju AK, Qiu Y, Perry RJ, Rahimi Y, Zhang X-M, Zhang D, Camporez J-PG, Cline GW, Butrico GM, Kemp BE, Casals G, Steinberg GR, Vatner DF, Petersen KF, Shulman GI (2018) Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med Available at: http://www.nature.com/articles/s41591-018-0125-4 [Accessed August 22, 2018] 24:1384–1394

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Malin SK, Gerber R, Chipkin SR, Braun B (2012) Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 35:131–136

    Article  CAS  PubMed  Google Scholar 

  • Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin M-J, Schwab M, Pollak M, Zhang Y, Yu Y, Becker KG, Bohr VA, Ingram DK, Sinclair DA, Wolf NS, Spindler SR, Bernier M, de Cabo R (2013) Metformin improves healthspan and lifespan in mice. Nat Commun 4:2192

    Article  CAS  PubMed  Google Scholar 

  • Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R (2011) Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci 66:191–201

    Article  CAS  PubMed  Google Scholar 

  • Miller ME, Williamson JD, Gerstein HC, Byington RP, Cushman WC, Ginsberg HN, Ambrosius WT, Lovato L, Applegate WB (2014a) Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial. Diabetes Care 37:634–643

    Article  PubMed  PubMed Central  Google Scholar 

  • Miller RA, Harrison DE, Astle CM, Fernandez E, Flurkey K, Han M, Javors MA, Li X, Nadon NL, Nelson JF, Pletcher S, Salmon AB, Sharp ZD, Van Roekel S, Winkleman L, Strong R (2014b) Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell 13:468–477

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nadon NL, Strong R, Miller RA, Nelson J, Javors M, Sharp ZD, Peralba JM, Harrison DE (2008) Design of aging intervention studies: the NIA interventions testing program. Age Dordr Neth 30:187–199

    Article  CAS  Google Scholar 

  • Ng TP, Feng L, Yap KB, Lee TS, Tan CH, Winblad B (2014) Long-term metformin usage and cognitive function among older adults with diabetes. J Alzheimers Dis 41:61–68

    Article  CAS  PubMed  Google Scholar 

  • Onken B, Driscoll M (2010) Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS One 5:e8758

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348:607–614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140–1142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Peterson C, Grace Walton R, Craig Tuggle S, Kulkarni A (2018) Metformin to augment strength training effective response in seniors: the masters trial. Innov Aging 2:544–545

    Article  PubMed Central  Google Scholar 

  • Physical Activity Committee (2018) Scientific Report - 2018 Physical Activity Guidelines - health.gov. Available at: https://health.gov/paguidelines/second-edition/report/

  • Preiss D, Lloyd SM, Ford I, McMurray JJ, Holman RR, Welsh P, Fisher M, Packard CJ, Sattar N (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes Endocrinol 2:116–124

    Article  CAS  PubMed  Google Scholar 

  • Reed RL, Pearlmutter L, Yochum K, Meredith KE, Mooradian AD (1991) The relationship between muscle mass and muscle strength in the elderly. J Am Geriatr Soc 39:555–561

    Article  CAS  PubMed  Google Scholar 

  • Reid KF, Fielding RA (2012) Skeletal muscle power: a critical determinant of physical functioning in older adults. Exerc Sport Sci Rev 40:4–12

    Article  PubMed  PubMed Central  Google Scholar 

  • Reid KF, Naumova EN, Carabello RJ, Phillips EM, Fielding RA (2008) Lower extremity muscle mass predicts functional performance in mobility-limited elders. J Nutr Health Aging 12:493–498

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Seals DR, Justice JN, LaRocca TJ (2016) Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity. J Physiol 594:2001–2024

    Article  CAS  PubMed  Google Scholar 

  • Sharoff CG, Hagobian TA, Malin SK, Chipkin SR, Yu H, Hirshman MF, Goodyear LJ, Braun B (2010) Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individuals. Am J Physiol-Endocrinol Metab 298:E815–E823

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Smith DL, Elam CF, Mattison JA, Lane MA, Roth GS, Ingram DK, Allison DB (2010) Metformin supplementation and life span in Fischer-344 rats. J Gerontol A Biol Sci Med Sci 65:468–474

    Article  CAS  PubMed  Google Scholar 

  • Strong R, Miller RA, Antebi A, Astle CM, Bogue M, Denzel MS, Fernandez E, Flurkey K, Hamilton KL, Lamming DW, Javors MA, de Magalhães JP, Marinez PA, McCord JM, Miller BF, Müller M, Nelson JF, Ndukum J, Rainger GE, Richardson A, Sabatini DM, Salmon AB, Simpkins JW, Steegenga WT, Nadon NL, Harrison DE (2016) Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging Cell 15:872–884

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • UKPDS Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet Lond Engl 352:854–865

    Article  Google Scholar 

  • Wang J, Gallagher D, DeVito LM, Cancino GI, Tsui D, He L, Keller GM, Frankland PW, Kaplan DR, Miller FD (2012) Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation. Cell Stem Cell 11:23–35

    Article  CAS  PubMed  Google Scholar 

  • Weiss R, Fernandez E, Liu Y, Strong R, Salmon AB (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging 10:386–401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wessels B, Ciapaite J, van den Broek NMA, Nicolay K & Prompers JJ (2014) Metformin impairs mitochondrial function in skeletal muscle of both lean and diabetic rats in a dose-dependent manner. PLoS One 9. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065055/ [Accessed April 15, 2015]

  • Wheaton WW, Weinberg SE, Hamanaka RB, Soberanes S, Sullivan LB, Anso E, Glasauer A, Dufour E, Mutlu GM, Budigner GS, Chandel NS (2014) Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife 3:e02242

    Article  PubMed  PubMed Central  Google Scholar 

  • Williams GC (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11(4):398–411. http://doi.org/jstor.org/stable/2406060

  • Williams PT (2001) Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc 33:754–761

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu JW, Boudreau DM, Park Y, Simonds NI, Freedman AN (2014) Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature. Expert Opin Drug Saf 13:1071–1099

    Article  CAS  PubMed  Google Scholar 

  • Zampieri S, Pietrangelo L, Loefler S, Fruhmann H, Vogelauer M, Burggraf S, Pond A, Grim-Stieger M, Cvecka J, Sedliak M, Tirpáková V, Mayr W, Sarabon N, Rossini K, Barberi L, De Rossi M, Romanello V, Boncompagni S, Musarò A, Sandri M, Protasi F, Carraro U, Kern H (2015) Lifelong physical exercise delays age-associated skeletal muscle decline. J Gerontol A Biol Sci Med Sci 70:163–173

    Article  CAS  PubMed  Google Scholar 

  • Zhou K, Donnelly L, Yang J, Li M, Deshmukh H, Van Zuydam N, Ahlqvist E, Wellcome Trust Case Control Consortium 2, Spencer CC, Groop L, Morris AD, Colhoun HM, Sham PC, McCarthy MI, Palmer CNA, Pearson ER (2014) Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis. Lancet Diabetes Endocrinol 2:481–487

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL, USA

    Adam R. Konopka

  2. Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA

    Adam R. Konopka

  3. Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

    Benjamin F. Miller

Authors
  1. Adam R. Konopka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Benjamin F. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Benjamin F. Miller.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Konopka, A.R., Miller, B.F. Taming expectations of metformin as a treatment to extend healthspan. GeroScience 41, 101–108 (2019). https://doi.org/10.1007/s11357-019-00057-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11357-019-00057-3

Keywords

Search

Navigation